Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions

Table 2 Number of animals with a IHC score ≥ 1 per lymphoid tissue and number of animals with at least one tissue scored ≥1 per treatment group

Treatment	Number of animals with a IHC score ≥ 1 per lymphoid tissue				Number of animals with at least one tissue scored ≥1 per treatment group
Treatment	TO	TBLN	MSLN	ISLN
NV-NC	0^a	0^a	0 ^a	0 ^a	0^a (0%)
NV-C PCV-2	5^a (35.7%)	8^b (57.1%)	2^a (14.3%)	4^a (28.6%)	9^b (64.2%)
VS-C PCV-2	0^a	0 ^a	0^a	0^a	0^a (0%)
VC-C PCV-2	1^a (7.1%)	2^{a, b} (14.3%)	1^a (7.1%)	1^a (7.1%)	2^a (14.2%)

Different letters in superscript within a column means p < 0.05
TO Tonsil, TBLN Tracheobronchial lymph node, MSLN Mesenteric lymph node, ISLN Superficial inguinal lymph node, LD Lymphocyte depletion, HI Histiocytic infiltration, IHC Immunohistochemistry

ISSN: 2055-5660